Major trial design shift: oral low-dose antiplatelet combo in minor stroke

A multicenter Chinese randomized trial found that a low-dose ticagrelor plus aspirin regimen halved early neurological deterioration in high-risk minor stroke compared with clopidogrel plus aspirin. The study reported no increase in bleeding risk, presenting a practical regimen alternative for rapid early-risk reduction.